WO2008064815A3 - Préparation pour l'administration transdermique de galanthamine - Google Patents
Préparation pour l'administration transdermique de galanthamine Download PDFInfo
- Publication number
- WO2008064815A3 WO2008064815A3 PCT/EP2007/010112 EP2007010112W WO2008064815A3 WO 2008064815 A3 WO2008064815 A3 WO 2008064815A3 EP 2007010112 W EP2007010112 W EP 2007010112W WO 2008064815 A3 WO2008064815 A3 WO 2008064815A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- galanthamine
- transdermally administering
- transdermally
- administering galanthamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
L'invention concerne une préparation pour l'administration transdermique de galanthamine, caractérisée en ce que la galanthamine, ou l'un de ses sels pharmaceutiquement acceptable, est amené en l'état de résorption transdermique dans une émulsion non huileuse.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006056783.8 | 2006-12-01 | ||
DE102006056783A DE102006056783A1 (de) | 2006-12-01 | 2006-12-01 | Zubereitung zur transdermalen Verabreichung von Galanthamin |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008064815A2 WO2008064815A2 (fr) | 2008-06-05 |
WO2008064815A3 true WO2008064815A3 (fr) | 2008-07-17 |
Family
ID=39247230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2007/010112 WO2008064815A2 (fr) | 2006-12-01 | 2007-11-22 | Préparation pour l'administration transdermique de galanthamine |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102006056783A1 (fr) |
WO (1) | WO2008064815A2 (fr) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004002402A2 (fr) * | 2002-05-21 | 2004-01-08 | Nastech Pharmaceutical Company Inc. | Administration d'inhibiteurs d'acetylcholinesterase au liquide cephalorachidien spinal |
US20040185170A1 (en) * | 2003-03-21 | 2004-09-23 | Shubha Chungi | Method for coating drug-containing particles and formulations and dosage units formed therefrom |
US20050074487A1 (en) * | 1999-12-16 | 2005-04-07 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
WO2005039531A1 (fr) * | 2003-10-10 | 2005-05-06 | Antares Pharma Ipl Ag | Formulation pharmaceutique transdermique visant a reduire les residus sur la peau |
WO2005102268A2 (fr) * | 2004-04-22 | 2005-11-03 | Sanochemia Pharmazeutika Ag | Inhibiteurs de la cholinesterase inclus dans des liposomes, leur production et leur utilisation |
WO2007016766A1 (fr) * | 2005-08-05 | 2007-02-15 | Nuvo Research Inc. | Formulation pour l'administration transdermique de medicaments |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9007052D0 (en) * | 1990-03-29 | 1990-05-30 | Skua Investments Ltd | Pharmaceutical formulations |
US5945409A (en) * | 1995-03-10 | 1999-08-31 | Wilson T. Crandall | Topical moisturizing composition and method |
HU227182B1 (en) * | 2000-03-06 | 2010-09-28 | Andras Javor | Lecitin-ascorbic acid combination |
-
2006
- 2006-12-01 DE DE102006056783A patent/DE102006056783A1/de not_active Withdrawn
-
2007
- 2007-11-22 WO PCT/EP2007/010112 patent/WO2008064815A2/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050074487A1 (en) * | 1999-12-16 | 2005-04-07 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
WO2004002402A2 (fr) * | 2002-05-21 | 2004-01-08 | Nastech Pharmaceutical Company Inc. | Administration d'inhibiteurs d'acetylcholinesterase au liquide cephalorachidien spinal |
US20040185170A1 (en) * | 2003-03-21 | 2004-09-23 | Shubha Chungi | Method for coating drug-containing particles and formulations and dosage units formed therefrom |
WO2005039531A1 (fr) * | 2003-10-10 | 2005-05-06 | Antares Pharma Ipl Ag | Formulation pharmaceutique transdermique visant a reduire les residus sur la peau |
WO2005102268A2 (fr) * | 2004-04-22 | 2005-11-03 | Sanochemia Pharmazeutika Ag | Inhibiteurs de la cholinesterase inclus dans des liposomes, leur production et leur utilisation |
WO2007016766A1 (fr) * | 2005-08-05 | 2007-02-15 | Nuvo Research Inc. | Formulation pour l'administration transdermique de medicaments |
Also Published As
Publication number | Publication date |
---|---|
DE102006056783A1 (de) | 2008-06-05 |
WO2008064815A2 (fr) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010150995A3 (fr) | Compositions de traitement de la dépendance aux drogues et d'amélioration du comportement lié aux dépendances | |
WO2008070149A3 (fr) | Promédicaments et procédés pour les fabriquer et les utiliser | |
WO2007126964A3 (fr) | Inhibiteurs de kinase | |
EP2562177A3 (fr) | Promédicaments de buprenorphine administrables de façon transdermique et leurs compositions empêchant une utilisation abusive | |
WO2007135193A3 (fr) | Forme pharmaceutique orale multimicroparticulaire a liberation prolongee comprenant des moyens anti-mesusage et resistant a l'alcool | |
WO2007092755A3 (fr) | Traitement de l'insuffisance et de la deficience de vitamine d avec de la 25-hydroxyvitamine d2 et de la 25-hydroxyvitamine d3 | |
WO2008061226A3 (fr) | Formulations de topiramate à libération prolongée | |
WO2004075832A3 (fr) | Methodes et compositions de traitement de douleurs chroniques au moyen de la dhea et de derives de celle-ci | |
WO2010041017A3 (fr) | Émulsions gélifiées pouvant être mâchées | |
WO2005107711A3 (fr) | Procede et composition permettant de traiter la rhinite | |
WO2007018588A8 (fr) | Composition pharmaceutique stable comprenant la forme iv de linézolide | |
WO2007138466A3 (fr) | Compositions pharmaceutiques comprenant une combinaison de meloxicam et de tramadol | |
WO2009045795A3 (fr) | Formulations galéniques de composés organiques | |
MX2009012782A (es) | Formulaciones para administracion oral de agentes terapeuticos y metodos relacionados. | |
WO2010090494A3 (fr) | Utilisation médicale de dérivés d'acide 5-benzylaminosalicylique ou de sels correspondants | |
EP1902715A3 (fr) | Utilisation de la palipéridone pour le traitement de patients psychiatriques avec une fonction hépatique déficiente | |
WO2007133796A3 (fr) | Procédés et compositions de traitement de l'apnée du sommeil | |
EP2392335A3 (fr) | Utilisation de 24-norUDCA | |
WO2005120518A3 (fr) | Utilisation d'analogues d'atp pour le traitement des maladies cardio-vasculaires | |
WO2009045053A3 (fr) | Sensibilisant du cancer comprenant un acide chlorigénique | |
WO2008051527A3 (fr) | Libération prolongée d'agents pour la gestion d'une douleur localisée | |
WO2006015970A3 (fr) | Medicaments pour la prevention ou le traitement de la pneumonie alveolaire comprenant un anticholinergique | |
WO2008063847A3 (fr) | Méthode de traitement de l'autisme | |
WO2006128152A3 (fr) | Procede de traitement et de prevention de l'opacification de la capsule posterieure | |
WO2006079625A3 (fr) | Medicaments pour prevenir ou pour traiter une insuffisance cardiaque et methode consistant a administrer un anticholinergique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07856217 Country of ref document: EP Kind code of ref document: A2 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007856217 Country of ref document: EP |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07856217 Country of ref document: EP Kind code of ref document: A2 |